Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity

被引:59
作者
Yadav, Inderjit S. [1 ,2 ]
Nandekar, Prajwal P. [3 ]
Shrivastava, Shambhavi [1 ]
Sangamwar, Abhay [3 ]
Chaudhury, Ashok [2 ]
Agarwal, Subhash Mohan [1 ]
机构
[1] Inst Cytol & Prevent Oncol, Bioinforrnat Div, Noida 201301, India
[2] Guru Jambheshwar Univ Sci & Technol, Dept Bio & Nano Technol, Hisar, Haryana, India
[3] NIPER, Dept Pharmacoinformat, Sas Nagar, Punjab, India
关键词
EGFR; Tyrosine kinase; Curcumin; Ensemble docking; Molecular dynamics; ANTICANCER AGENTS; ANTITUMOR AGENTS; PROSTATE-CANCER; LUNG-CANCER; KAPPA-B; ANALOGS; INHIBITOR; DESIGN; INSIGHTS; DISEASE;
D O I
10.1016/j.gene.2014.01.056
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Epidermal growth factor receptor tyrosine kinase (EGFR-TK) is an attractive target for cancer therapy. Despite a number of effective EGFR inhibitors that are constantly expanding and different methods being employed to obtain novel compounds, the search for newer EGFR inhibitors is still a major scientific challenge. In the present study, a molecular docking and molecular dynamics investigation has been carried out with an ensemble of EGFR-TK structures against a synthetically feasible library of curcumin analogs to discover potent EGFR inhibitors. To resolve protein flexibility issue we have utilized 5 EGFR wild type crystal structures during docking as this gives improved possibility of identifying an active compound as compared to using a single crystal structure. We then identified five curcumin analogs representing different scaffolds that can serve as lead molecules. Finally, the 5 ns molecular dynamics simulation shows that knoevenagel condensate of curcumin specifically C29 and C30 can be used as starting blocks for developing effective leads capable of inhibiting EGFR. (c) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 41 条
[1]  
Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
[2]   Curcumin and Its Analogues: Potential Anticancer Agents [J].
Agrawal, Dinesh Kumar ;
Mishra, Pushpesh Kumar .
MEDICINAL RESEARCH REVIEWS, 2010, 30 (05) :818-860
[3]   Synthesis, Characterisation, and In Vitro Anticancer Activity of Curcumin Analogues Bearing Pyrazole/Pyrimidine Ring Targeting EGFR Tyrosine Kinase [J].
Ahsan, Mohamed Jawed ;
Khalilullah, Habibullah ;
Yasmin, Sabina ;
Jadav, Surender Singh ;
Govindasamy, Jeyabalan .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[4]   CASTp: Computed atlas of surface topography of proteins [J].
Binkowski, TA ;
Naghibzadeh, S ;
Liang, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3352-3355
[5]   The Amber biomolecular simulation programs [J].
Case, DA ;
Cheatham, TE ;
Darden, T ;
Gohlke, H ;
Luo, R ;
Merz, KM ;
Onufriev, A ;
Simmerling, C ;
Wang, B ;
Woods, RJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1668-1688
[6]   Biodiversity: A continuing source of novel drug leads [J].
Cragg, GM ;
Newman, DJ .
PURE AND APPLIED CHEMISTRY, 2005, 77 (01) :7-24
[7]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
[8]   Natural products as leads to anticancer drugs [J].
Gordaliza, M. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (12) :767-776
[9]   Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors [J].
Handler, Norbert ;
Jaeger, Walter ;
Puschacher, Helmut ;
Leisser, Klaus ;
Erker, Thomas .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (01) :64-71
[10]   ErbB receptors: Directing key signaling networks throughout life [J].
Holbro, T ;
Hynes, NE .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :195-217